Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction

• Status: Completed
• Trial end date: 2006-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer

Criteria

Inclusion Criteria:

• At least 8 weeks post-documented myocardial infarction (heart attack)

Exclusion Criteria:

• History of radiation therapy to the chest

• Clinically unstable

• Any contraindication for MRI